Aurora Cannabis (TSE:ACB) Stock Price Up 8.2%

Aurora Cannabis Inc. (TSE:ACB)’s share price rose 8.2% during trading on Thursday . The stock traded as high as C$8.72 and last traded at C$8.70. Approximately 904,213 shares traded hands during mid-day trading, a decline of 26% from the average daily volume of 1,221,178 shares. The stock had previously closed at C$8.04.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on ACB shares. CIBC reduced their price target on Aurora Cannabis to C$6.00 and set a “neutral” rating for the company in a report on Wednesday, February 21st. Jefferies Financial Group reduced their price objective on shares of Aurora Cannabis from C$6.12 to C$4.95 and set a “hold” rating for the company in a research note on Tuesday, February 27th. Finally, Canaccord Genuity Group raised shares of Aurora Cannabis from a “hold” rating to a “buy” rating and set a C$0.80 target price for the company in a report on Friday, February 9th.

Aurora Cannabis Stock Up 11.1 %

The stock has a market cap of C$487.04 million, a PE ratio of -0.11 and a beta of 2.83. The company has a debt-to-equity ratio of 18.51, a current ratio of 3.79 and a quick ratio of 2.48. The company has a 50 day moving average price of C$5.06 and a two-hundred day moving average price of C$2.18.

Aurora Cannabis (TSE:ACB) last released its quarterly earnings data on Thursday, February 8th. The company reported C($0.20) EPS for the quarter, missing the consensus estimate of C($0.10) by C($0.10). The business had revenue of C$72.61 million during the quarter, compared to the consensus estimate of C$63.50 million. Aurora Cannabis had a negative return on equity of 137.28% and a net margin of 151.71%. Analysts expect that Aurora Cannabis Inc. will post -0.22 EPS for the current year.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.